Search clinical trials for: Tadalafil 5mg

Total 12541 results

Assiut University

Not yet recruiting

(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia
Ascletis Pharmaceuticals Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

China
University of Florence

Completed

Tadalafil Plus Tamsulosin for Male LUTS and ED

Lower Urinary Tract Symptoms | Metabolic Syndrome | Erectile Dysfunction | Prostatic Hyperplasia, Benign
University of Pernambuco

Unknown

Efficacy and Safety of Tadalafil in Hemodialysis Patients

Erectile Dysfunction

Brazil
Pfizer

Completed

A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia

Schizophrenia

United States
Cedars-Sinai Medical Center

Completed

PDE Inhibitors in DMD Study (Acute Dosing Study)

Duchenne Muscular Dystrophy

United States
Mark Feinglos
Eli Lilly and Company; Duke University

Withdrawn

Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

Nausea | Vomiting | Gastroparesis | Diabetic Gastroparesis

United States
Helixmith Co., Ltd.

Completed

Safety Study of Gene Therapy in Treating Lower Leg Ischemia

Critical Limb Ischemia

United States
Erasmus Medical Center

Completed

A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer

Erectile Dysfunction | Prostate Cancer

Netherlands
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients

Benign Prostatic Hyperplasia

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Completed

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

Healthy Volunteer

China
Ankara Training and Research Hospital

Recruiting

Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment

Erectile Dysfunction

Turkey
Govind Ballabh Pant Hospital

Completed

Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome

Eisenmenger Syndrome

India
University of Zurich

Completed

The Effect of L-lysine on Human Gastrointestinal Secretion: A Dose-finding Study Applying Magnetic Resonance Imaging (MRI)

Healthy

Switzerland
Eli Lilly and Company

Completed

Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension
HealthCore-NERI
Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure (PITCH-HF)

Heart Failure | Pulmonary Hypertension

United States, Canada
Eli Lilly and Company
ICOS Corporation

Completed

Tadalafil in Subjects With Mild to Moderate Hypertension

Hypertension

United States
University of Manitoba
Manitoba Medical Service Foundation; Rick Hansen Foundation

Completed

Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males

Hypotension | Spinal Cord Injury

Canada
Pfizer

Completed

Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction

Impotence
Santa Barbara Cottage Hospital

Withdrawn

The Use of Tadalafil in Confirmed COVID-19 Pneumonia.

COVID | ARDS, Human | Sars-CoV2
American University of Beirut Medical Center

Unknown

The Effect of Bread Fortification With Phosphorus and Lysine on Postprandial Glycaemia and Thermogenesis

Postprandial Hyperglycemia | Energy Expenditure

Lebanon
Johns Hopkins University
Eli Lilly and Company

Withdrawn

Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia

Priapism | Sickle Cell Anemia

United States
Eli Lilly and Company
ICOS Corporation

Completed

Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life

Impotence

United States, Austria, France, Germany, Mexico
Eli Lilly and Company
ICOS Corporation

Completed

Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying

Gastroparesis

Canada
Eli Lilly and Company
ICOS Corporation

Completed

A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg

Erectile Dysfunction

United States
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

Evaluate the Effects of Food on the Pharmacokinetics of Fadanafil in Healthy Subjects

Healthy

China
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

Hypertension, Pulmonary

United States, Belgium, Canada, France, Germany, Ireland, Italy, Japan, Spain, United Kingdom
Eli Lilly and Company

Completed

Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily

Benign Prostatic Hyperplasia

Italy, United States, Germany, Mexico, Argentina
Eli Lilly and Company

Completed

Effect of Tadalafil Once a Day in Men With Erectile Dysfunction

Erectile Dysfunction

Germany, Spain, Italy, Greece, Poland
Eli Lilly and Company
ICOS Corporation

Completed

Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction

Erectile Dysfunction | Impotence

Finland
Eli Lilly and Company
ICOS Corporation

Completed

Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury

Erectile Dysfunction | Spinal Cord Injuries

United States
Eli Lilly and Company
ICOS Corporation

Completed

To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

Impotence

United States
Eli Lilly and Company
ICOS Corporation

Completed

Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects

Impotence

Sweden
Vanderbilt University
National Institutes of Health (NIH)

Completed

Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

Metabolic Syndrome
TWi Biotechnology, Inc.

Completed

Study of AC-201 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Taiwan
Eli Lilly and Company

Completed

A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States, Spain, France, Poland, Canada, United Kingdom
Lawson Health Research Institute
Delivra, Inc.

Withdrawn

Tadalafil-Delivra and Raynaud's Phenomenon

Raynaud Phenomenon

Canada
Eli Lilly and Company
ICOS Corporation

Completed

Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Eli Lilly and Company
ICOS Corporation

Completed

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Pulmonary Hypertension

France, United States, Italy
Philip Kern
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics

Obesity | Pre-diabetes

United States
Eli Lilly and Company
ICOS Corporation

Completed

A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months

Erectile Dysfunction

United States
Eli Lilly and Company
ICOS Corporation

Completed

To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking

Impotence

United States
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

Impotence

Germany
Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Cardiac Edema (CHF)

Japan
GlaxoSmithKline
Gilead Sciences

Completed

A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) (AMBITION)

Hypertension, Pulmonary

France, Spain, Germany, Sweden, Australia, United Kingdom, United States, Belgium, Japan, Netherlands, Canada, Italy, Austria, Greece
Eli Lilly and Company
ICOS Corporation

Completed

A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction

Erectile Dysfunction

United States
Eli Lilly and Company
ICOS Corporation

Completed

Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems (PILUTS)

Prostatic Hyperplasia | Prostate

United States
Eli Lilly and Company
ICOS Corporation

Completed

Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection

Impotence

China
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

Impotence

Japan

Search clinical trials for: Tadalafil 5mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations